|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2006-8-28
|
|
pubmed:abstractText |
Recent studies of conventional chemotherapeutic drugs administered in metronomic therapy schedules showed remarkable inhibitory effects on tumor angiogenesis. Subsequent and prolonged tumor regression was achieved moreover by circumventing acquired drug resistance. In this study, metronomic and conventional trofosfamide were compared on human NSCLC xenograft "LX-1."
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0171-5216
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
132
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
643-52
|
|
pubmed:meshHeading |
pubmed-meshheading:16761121-Angiogenesis Inhibitors,
pubmed-meshheading:16761121-Animals,
pubmed-meshheading:16761121-Antineoplastic Agents, Alkylating,
pubmed-meshheading:16761121-Apoptosis,
pubmed-meshheading:16761121-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16761121-Cyclophosphamide,
pubmed-meshheading:16761121-Drug Administration Schedule,
pubmed-meshheading:16761121-Endothelial Cells,
pubmed-meshheading:16761121-Female,
pubmed-meshheading:16761121-Humans,
pubmed-meshheading:16761121-Inhibitory Concentration 50,
pubmed-meshheading:16761121-Lung Neoplasms,
pubmed-meshheading:16761121-Mice,
pubmed-meshheading:16761121-Mice, Nude,
pubmed-meshheading:16761121-Time Factors,
pubmed-meshheading:16761121-Tumor Cells, Cultured,
pubmed-meshheading:16761121-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effects.
|
|
pubmed:affiliation |
Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, 23538, Lubeck, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
